We've launched a Drug Repurposing Open Call with our partners Findacure, Cures Within Reach and CureAccelerator. Are you a patient group, researcher or clinician with a drug repurposing idea for a rare disease? We want to help you.Contact us More details
Identification of existing drugs that can provide an accelerated route to treatment of rare diseases.Learn more
Predict whether an individual patient will respond to a drug, enabling development of diagnostic tests or selection of the right individuals for a clinical trial.Learn more
We work with patient groups and charities to identify existing drugs that could treat rare diseases, offering a cost effective way to improve patient quality of life.
Drug repurposing is the analysis of drugs already approved to treat one condition to see if they can be safe and effective for treating other diseases. Many drugs already on the market have been repurposed, examples include Aspirin, Thalidomide and the famous example Viagra which was co-invented by the Healx Chair, Dr David Brown.
Source: Tufts Centre for the Study of Drug Development (CSDD)Work with Healx
Cesare Spadoni, Founder and Chair of the Board, aPODD Foundation
Dr Rick Thompson, Head of Research, Findacure
Healx technology combines biological data analysis with advanced machine learning to match drugs with diseases. We combine this cutting edge technology with rare disease knowledge and drug development expertise to advance drug matching projects successfully to the next stage.
Each disease is unique and we tailor our predictions specifically for each condition.
Analysis of genomic signatures to match drugs with diseases.
Expert drug repurposing knowledge combined with insights gained from the voice of patients help us create better outcomes for all.
We use machine learning to analyse huge amounts of data and scan millions of scientific publications.
Our expertise, knowledge base and close collaboration with patient groups provides us with unique insight into rare diseases. We can help match your lead candidates to the ideal orphan indication, increasing the chance of discovering novel treatments for rare disease patients.Contact Us
We’ve built a free tool to help researchers, charities and individuals keep up with the latest scientific literature on hundreds of rare diseases. Sign up to be kept updated on your rare disease of interest.Try RareOmics